Dow Down 0.05% Nasdaq Up 0.29%

ImmunoGen, Inc. (IMGN)

-NasdaqGS
12.55 Up 0.73(6.18%) 10:41AM EDT - Nasdaq Real Time Price
Prev Close:11.82
Open:12.02
Bid:12.53 x 500
Ask:12.54 x 400
1y Target Est:15.27
Beta:1.75
Earnings Date:Oct 23 - Oct 27 (Est.)
Day's Range:12.01 - 12.74
52wk Range:10.28 - 18.34
Volume:438,822
Avg Vol (3m):822,718
Market Cap:1.08B
P/E (ttm):N/A
EPS (ttm):-0.78
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
IMGNUp 6.18%1.08B
PFEDown 0.37%185.66B
RHHBYDown 0.25%247.47B
SGENDown 3.41%5.25B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):16.95
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-15) :-0.72
Quarterly EPS Est (Sep-14) :-0.15
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ImmunoGen, Inc., a biotechnology company, develops targeted anticancer therapeutics. It develops its products using its antibody-drug conjugates technology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback